| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,385 | 23,255 | 23,475 | 12,490 | | Cost of Revenue | 11,056 | 20,476 | 14,467 | 7,630 | | | Gross Profit | 6,329 | 2,779 | 9,008 | 4,860 | | | Operating Expenses | | Research Development | 611 | 737 | 853 | 990 | | Selling General and Administrative | 11,162 | 7,181 | 7,792 | 6,570 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,444) | (5,139) | 363 | (2,700) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5) | 3 | 47 | 119 | | Earnings Before Interest And Taxes | (5,520) | (5,136) | 410 | (2,581) | | Interest Expense | (53) | 37 | 16 | 86 | | Income Before Tax | (5,467) | (5,173) | 394 | (2,667) | | Income Tax Expense | 3 | 33 | 28 | (20) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,470) | (5,206) | 366 | (2,647) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,470) | (5,206) | 366 | (2,647) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,470) | ($5,206) | $366 | ($2,647) |
|
0.51% Nasdaq 
Income Statement
